Patent: 10,377,731
✉ Email this page to a colleague
Summary for Patent: 10,377,731
Title: | Compositions and methods for cancer treatment |
Abstract: | The present invention relates to the composition and methods of use of Stat3 pathway inhibitors or cancer stem cell inhibitors in combination treatment of cancer. |
Inventor(s): | Li; Chiang Jia (Cambridge, MA), Mikule; Keith (Norwood, MA), Li; Youzhi (Westwood, MA) |
Assignee: | Boston Biomedical, Inc. (Cambridge, MA) |
Application Number: | 16/246,829 |
Patent Claims: | see list of patent claims |
Details for Patent 10,377,731
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 02/12/2004 | ⤷ Try a Trial | 2027-09-10 |
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 03/28/2007 | ⤷ Try a Trial | 2027-09-10 |
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2027-09-10 |
Amgen, Inc. | VECTIBIX | panitumumab | Injection | 125147 | 09/27/2006 | ⤷ Try a Trial | 2027-09-10 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |